The Spectrum of Minimal Change Disease/Focal Segmental Glomerulosclerosis: From Pathogenesis to Proteomic Biomarker Research
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26062450 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yuriy Maslyennikov und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Faculty of Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Glomerulosclerosis, Focal Segmental, Biomarkers, Nephrosis, Lipoid, Proteomics. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca.
Abstract (Originalsprache)
Podocyte injury plays a central role in both focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD). Pathogenic mechanisms are diverse and incompletely understood, partially overlap between FSGS and MCD, and are not reflected by kidney biopsy. In order to optimize the current variable response to treatment, personalized management should rely on pathogenesis. One promising approach involves identifying biomarkers associated with specific pathogenic pathways. With the advancement of technology, proteomic studies could be a valuable tool to improve knowledge in this area and define valid biomarkers, as they have in other areas of glomerular disease. This work attempts to cover and discuss the main mechanisms of podocyte injury, followed by a review of the recent literature on proteomic biomarker studies in podocytopathies. Most of these studies have been conducted on biofluids, while tissue proteomic studies applied to podocytopathies remain limited. While we recognize the importance of non-invasive biofluid biomarkers, we propose a sequential approach for their development: tissue proteomics could first identify proteins with increased expression that may reflect underlying disease mechanisms; subsequently, the validation of these proteins in urine or plasma could pave the way to a diagnostic and prognostic biomarker-based approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Faculty of Medicine, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
- Department of Personalized Medicine and Rare Diseases, MedFuture-Research Centre for Biomedical Research, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
- Department of Drug Analysis, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
ORCID-Profile: Andrada Alina Bărar, Maria Ticala, Alexandra Urs, Ioana Ecaterina Pralea, Cristina Adela Iuga, Diana Tania Moldovan, Ina Maria Kacso
Förderung
- Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca
- Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca
Zitieren
APA
Maslyennikov, Y., Bărar, A. A., Rusu, C. C., Potra, A. R., Tirinescu, D., Ticala, M., Urs, A., Pralea, I. E., Iuga, C. A., Moldovan, D. T., & Kacso, I. M. (2025). The Spectrum of Minimal Change Disease/Focal Segmental Glomerulosclerosis: From Pathogenesis to Proteomic Biomarker Research. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062450
Vancouver
Maslyennikov Y, Bărar AA, Rusu CC, Potra AR, Tirinescu D, Ticala M, et al. The Spectrum of Minimal Change Disease/Focal Segmental Glomerulosclerosis: From Pathogenesis to Proteomic Biomarker Research. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062450
BibTeX
@article{Maslyennikov2025,
author = {Maslyennikov, Yuriy and Bărar, Andrada Alina and Rusu, Crina Claudia and Potra, Alina Ramona and Tirinescu, Dacian and Ticala, Maria and Urs, Alexandra and Pralea, Ioana Ecaterina and Iuga, Cristina Adela and Moldovan, Diana Tania and Kacso, Ina Maria},
title = {The Spectrum of Minimal Change Disease/Focal Segmental Glomerulosclerosis: From Pathogenesis to Proteomic Biomarker Research},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26062450}
}
EUVIMED